Ralph Carmona was watching his son run the 2014 Boston Marathon when he felt inspired to complete the course himself. He hadn ...

BioArctic AB (publ) (NASDAQ Stockholm: BIOA B) today welcomes investors, analysts and financial media to the company's Capital Markets Day. The event, which starts at 10:30 CET, will be broadcast live ...

Founded in 1998 by Leonard A. and Ronald S. Lauder, the Alzheimer's Drug Discovery Foundation is dedicated to rapidly ...

The Lumipulse blood test became the first “in vitro diagnostic device” to be endorsed by the U.S. Food and Drug ...

Biogen Inc. (NASDAQ: BIIB )’s recent partnership with City Therapeutics, Inc. to develop RNAi therapies for central nervous ...

In calling for more clinical testing of vaccines in younger people and those who face a low risk of severe disease from Covid ...

In 2024, the European Medicines Agency (EMA) approved lecanemab for the treatment of early Alzheimer's disease in patients without contraindications or risk factors for side-effects. This approval ...

The FDA approved a test that can help clinicians diagnose Alzheimer's disease early on using a simple blood draw. The test ...

Pfizer is paying $1.25 billion to join the PD-(L1)xVEGF bispecific race. | Pfizer is paying $1.25 billion to join the ...

French pharma giant Sanofi SNY recently announced that it has agreed to acquire Massachusetts-based biotech Vigil ...

A report found that the world's youngest Alzheimer's patient is actually a 19-year-old boy. He first started showing signs at ...

The test may make it easier to identify whether people with memory and thinking problems have Alzheimer’s or not.